-
First look at the global chemical probes market
We recently announced that our team here at CiteAb has expanded our platform...May 11, 2017 -
We’re working with the GBSI to improve ICC antibody validation
Our founder, Dr Andrew Chalmers, is leading an Antibody Validation Working Group for the...May 3, 2017 -
What are the most important antibody targets for immunocytochemistry?
New to our series of blogs on antibody research applications, today we are exploring...April 24, 2017 -
CiteAb: now more than just antibodies!
Here at CiteAb we have recently developed our technology so that we can now...April 11, 2017 -
Which antibodies for zebrafish are the most used?
As the vast majority of commercial antibodies are raised against human proteins, we became...April 4, 2017 -
Reporting from Alpbach – three ways to validate antibodies
Last week our founder Dr Andrew Chalmers was in Alpbach for the 8th Affinity...March 22, 2017 -
We’re recruiting! Graduate developer wanted to join our team.
THE DEADLINE FOR APPLICATIONS HAS NOW CLOSED Here at CiteAb...March 21, 2017 -
We’re recruiting! Biologist or Chemist wanted to join our team.
THE DEADLINE FOR APPLICATIONS HAS NOW CLOSED Here at CiteAb...March 14, 2017 -
Winner profile: custom antibody or alternative affinity reagent supplier
We recently announced the winners of the 2017 CiteAb Antibody Awards, and today we...March 9, 2017 -
Winner profile: Antibody Validation Initiative 2017
We recently announced the winners of the 2017 CiteAb Antibody Awards, and today we...March 3, 2017 -
Winner profile: Researchers’ Choice award 2017
We recently announced the winners of the 2017 CiteAb Antibody Awards, and today we...February 22, 2017 -
Monoclonals take pole position
For the first time in 42 years, use of monoclonal antibodies has overtaken polyclonals...February 15, 2017
